At this time last year, the health ministry spokesman was tracking the progress of the “doubling” rate, the number of days it took for the daily tally of cases to double. The rate tracked a flattening of the curve of new cases, the peak being just under 100,000 in September before it fell to barely 10,000.
Other countries saw second and third waves of infection, but India shifted into triumphalist mode. Now consider the present doubling rate: eight days to double from 20,000 to 40,000, 14 days to re-double to 80,000, and then 10 days to double yet again to 160,000. A fourth ...
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs
Key stories on business-standard.com are available to premium subscribers only.
Already a premium subscriber? LOGIN NOW
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
Copyrights © 2021 Business Standard Private Ltd. All rights reserved.
RECOMMENDED FOR YOU